• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用反射式共聚焦显微镜监测3%双氯芬酸钠2.5%透明质酸对场癌化的治疗:组织学相关性

Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.

作者信息

Malvehy Josep, Roldán-Marín Rodrigo, Iglesias-García Pablo, Díaz Alba, Puig Susana

机构信息

Melanoma Unit, Dermatology Department, Hospital Clinic, ES-08036 Barcelona,, Spain.

出版信息

Acta Derm Venereol. 2015 Jan;95(1):45-50. doi: 10.2340/00015555-1860.

DOI:10.2340/00015555-1860
PMID:24696069
Abstract

Visual inspection may fail to accurately evaluate field cancerisation (subclinical actinic keratoses [AKs]). We aimed to describe field cancerisation by confocal reflectance microscopy and changes induced by the application of 3% diclofenac sodium gel in 2.5% hyaluronic acid. Fourteen male patients, > 50 years old, with AKs on the bald scalp were included. Clinical examination, confocal microscopy and histological study of clinically visible lesions and "normal appearing" adjacent skin before and after treatment was completed. Reflectance confocal microscopy showed a decrease in scaling (p = 0.001) and atypia of the honeycomb pattern (p = 0.001) at 2 weeks of treatment. Changes in parakeratosis, inflammation and dermal collagen remodelling were also observed. Histology correlated with confocal features in AK and subclinical AK. Reflectance confocal microscopy was useful in the evaluation of field cancerisation and monitoring of treatment response. A rapid improvement in epidermal atypia was observed.

摘要

肉眼检查可能无法准确评估场癌化(亚临床光化性角化病[AKs])。我们旨在通过共聚焦反射显微镜描述场癌化情况,以及应用含2.5%透明质酸的3%双氯芬酸钠凝胶所引起的变化。纳入了14名年龄大于50岁、秃头皮上患有AKs的男性患者。在治疗前后,对临床可见病变及“外观正常”的相邻皮肤进行了临床检查、共聚焦显微镜检查和组织学研究。反射式共聚焦显微镜显示,治疗2周时鳞屑减少(p = 0.001),蜂巢状模式的异型性降低(p = 0.001)。还观察到角化不全、炎症和真皮胶原重塑的变化。组织学与AK和亚临床AK中的共聚焦特征相关。反射式共聚焦显微镜有助于评估场癌化和监测治疗反应。观察到表皮异型性迅速改善。

相似文献

1
Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.用反射式共聚焦显微镜监测3%双氯芬酸钠2.5%透明质酸对场癌化的治疗:组织学相关性
Acta Derm Venereol. 2015 Jan;95(1):45-50. doi: 10.2340/00015555-1860.
2
Management of clinical and subclinical actinic keratoses with histological and immunohistochemical assessments by confocal microscopy.应用共聚焦显微镜进行临床和亚临床光化性角化病的组织学和免疫组织化学评估及处理。
Dermatol Ther. 2018 Sep;31(5):e12672. doi: 10.1111/dth.12672. Epub 2018 Sep 11.
3
Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.外用双氯芬酸透明质酸治疗光化性角化病的场癌化证据。
Eur J Dermatol. 2014 Mar-Apr;24(2):158-67. doi: 10.1684/ejd.2014.2286.
4
Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.3.0%双氯芬酸 2.5%透明质酸凝胶局部治疗可诱导光化性角化病的癌前病变消退。
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):258-63. doi: 10.1111/j.1468-3083.2009.03399.x. Epub 2009 Aug 26.
5
Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.一项随机、安慰剂对照的研究,评估 3%双氯芬酸凝胶外用治疗多发性光化性角化病器官移植患者的安全性和疗效。
Eur J Dermatol. 2010 Jul-Aug;20(4):482-8. doi: 10.1684/ejd.2010.1010. Epub 2010 May 27.
6
Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.低剂量 5-氟尿嘧啶联合水杨酸作为一种新的皮损定向治疗外用光化性角化病的方法:组织学和临床研究结果。
Br J Dermatol. 2011 Nov;165(5):1101-8. doi: 10.1111/j.1365-2133.2011.10387.x.
7
Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.光学相干断层扫描与反射式共聚焦显微镜联合用于监测0.5% 5-氟尿嘧啶和10%水杨酸治疗临床及亚临床光化性角化病的效果
J Eur Acad Dermatol Venereol. 2016 Feb;30(2):258-65. doi: 10.1111/jdv.13445. Epub 2015 Nov 4.
8
Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.双氯芬酸 3%/透明质酸 2.5%治疗光化性角化病的作用机制。
J Dtsch Dermatol Ges. 2011 Dec;9(12):1011-7. doi: 10.1111/j.1610-0387.2011.07700.x. Epub 2011 May 18.
9
In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.光化性角化病中0.5% 5-氟尿嘧啶/10%水杨酸场定向治疗的体内反射共聚焦显微镜特征
Dermatology. 2015;230(3):193-8. doi: 10.1159/000370148.
10
Actinic keratoses: non-invasive diagnosis for field cancerisation.光化性角化病:皮肤癌场癌化的非侵入性诊断
Br J Dermatol. 2007 May;156 Suppl 3:13-7. doi: 10.1111/j.1365-2133.2007.07865.x.

引用本文的文献

1
An Update on Non-Invasive Skin Imaging Techniques in Actinic Keratosis-A Narrative Review.光化性角化病的无创性皮肤成像技术更新:综述
Medicina (Kaunas). 2024 Jun 26;60(7):1043. doi: 10.3390/medicina60071043.
2
In Vivo Reflectance Confocal Microscopy as a Response Monitoring Tool for Actinic Keratoses Undergoing Cryotherapy and Photodynamic Therapy.体内反射共聚焦显微镜作为光化性角化病冷冻疗法和光动力疗法反应监测工具
Cancers (Basel). 2021 Oct 31;13(21):5488. doi: 10.3390/cancers13215488.
3
Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.
含光裂解酶的成膜医疗器械在光化性角化病场癌化管理中防治的10年临床证据综述
Dermatol Ther (Heidelb). 2019 Jun;9(2):259-270. doi: 10.1007/s13555-019-0294-1. Epub 2019 Apr 9.
4
Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.三尖杉酯碱纳米乳凝胶经皮给药制剂的研制:理化性质、经皮渗透、药代动力学和药效学特征。
J Nanobiotechnology. 2017 Dec 4;15(1):88. doi: 10.1186/s12951-017-0323-0.
5
[The aged scalp : A dermato-oncological focus point].[老年头皮:皮肤肿瘤学的一个焦点]
Hautarzt. 2017 Jun;68(6):437-444. doi: 10.1007/s00105-017-3988-2.
6
[Actinic keratoses].[光化性角化病]
Hautarzt. 2016 Nov;67(11):867-875. doi: 10.1007/s00105-016-3873-4.